There are two prophylaxis protocols currently in use for which there are long-term data: The Malmö protocol: 25–40 IU kg−1 per dose administered three times a week for those with hemophilia A, and twice a week for those with hemophilia B. The Utrecht protocol: 15–30 IU kg−1 per dose administered three times a week for those with hemophilia A, and twice a week for those with hemophilia B. However, many different

protocols are followed for prophylaxis, Palbociclib even within the same country, and the optimal regimen remains to be defined. The protocol should be individualized as much as possible based on age, venous access, bleeding phenotype, activity, and availability of clotting factor concentrates. One option for the treatment of very young children is to start prophylaxis once a week and escalate depending on bleeding and venous access. Prophylaxis is best given in the morning to cover periods

of activity. Prophylactic administration of clotting factor concentrates is advisable prior to engaging in activities with higher risk of injury. (Level 4) [ [34, 35, 18] ] Where appropriate and possible, persons with hemophilia should be managed in a home therapy setting. Home therapy allows immediate access to clotting factor and hence optimal early treatment, resulting in decreased pain, dysfunction, and long-term disability and significantly decreased hospital admissions for complications. (Level 3) [ [36, 37] ] Further improvements in quality of life include greater freedom to travel and participate in physical activities, BAY 57-1293 datasheet less absenteeism, and greater employment stability. [38] Home therapy is ideally achieved with clotting factor concentrates or other lyophilized products that are safe, can be stored in a domestic fridge, and are reconstituted easily. Home treatment must be supervised closely by the comprehensive care team and should only be initiated after adequate education and training. (Level Histamine H2 receptor 3) [ [36, 37] ] Teaching should focus on general knowledge of hemophilia; recognition of bleeds and common complications; first aid measures;

dosage calculation; preparation, storage, and administration of clotting factor concentrates; aseptic techniques; performing venipuncture (or access of central venous catheter); record keeping; proper storage and disposal of needles/sharps; and handling of blood spills. A certification program is helpful. Patients or parents should keep bleed records (paper or electronic) that include date and site of bleeding, dosage and lot number of product used, and adverse effects Infusion technique and bleed records should be reviewed and monitored at follow-up visits. Home care can be started with young children with adequate venous access and motivated family members who have undergone adequate training. Older children and teenagers can learn self-infusion with family support.